Skip to main content
    F

    Fortrea Holdings Inc. (FTRE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $21.96
    +1.50 (+7.33%)

    Market Cap: $1.97B

    Last updated: Nov 06, 2026 at 4:42 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(7/14)
    Avg Surprise
    -13.18%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.42
    Range$0.39 - $0.47
    7 analysts
    Revenue Consensus
    $731M
    Range$720M - $739M
    11 analysts
    Period ending Mar 31, 2027
    EPS Consensus$0.22
    Range$0.18 - $0.28
    7 analysts
    EPS RevisionsNo revisions (7d)
    4
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$0.23-0.6%
    60d ago$0.22+2.8%
    30d ago$0.22+2.1%
    7d ago$0.22+1.7%
    Current$0.22
    Revenue Consensus
    $666M
    Range$648M - $678M
    7 analysts
    Last 12 of 15 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Mar 27EST
    		-$0.22$0.18 - $0.28--7
    4
    2
    30d
    		-
    Dec 26EST
    		-$0.42$0.39 - $0.47--7--
    Sep 26
    Reported Oct 29
    		$0.28$0.24$0.16 - $0.28+16.67%Beat12
    1
    0
    30d
    		+133.3%
    Jun 26
    Reported Jul 29
    		$0.23$0.18$0.14 - $0.23+27.78%Beat11
    3
    3
    30d
    		+21.1%
    Mar 26
    Reported May 5
    		$0.16$0.05$-0.01 - $0.10+220.00%Beat9
    1
    5
    30d
    		+700.0%
    Dec 25
    Reported Feb 26
    		$0.09$0.16$0.13 - $0.21-43.75%Miss10
    1
    0
    30d
    		-50.0%
    Sep 25
    Reported Nov 5
    		$0.12$0.16$0.07 - $0.26-25.00%Miss11
    2
    0
    30d
    		-47.8%
    Jun 25
    Reported Aug 6
    		$0.19$0.08$0.02 - $0.20+137.50%Beat11
    0
    1
    30d
    		+733.3%
    Mar 25
    Reported May 12
    		$0.02N/A-+128.57%Beat9
    0
    6
    30d
    		+150.0%
    Dec 24
    Reported Mar 3
    		$0.18N/A--50.73%Miss11
    0
    2
    30d
    		-5.3%
    Sep 24
    Reported Nov 8
    		$0.23$0.25$0.18 - $0.31-8.00%Miss11
    No revisions (30d)
    		-4.2%
    Jun 24
    Reported Aug 12
    		$-0.03$0.06--150.00%Miss11
    1
    0
    30d
    		-105.8%
    Mar 24
    Reported May 13
    		$-0.04$0.01$-0.10 - $0.06-500.00%Miss7
    No revisions (30d)
    		-108.8%
    Dec 23
    Reported Mar 11
    		$0.19$0.24$0.05 - $0.24-20.83%Miss3
    No revisions (30d)
    		-

    Key Metrics

    Valuation
    P/E Ratio28.89EV/EBITDA27.40x
    Price/FCF12.54xFCF Yield7.97%
    Profitability
    Profit Margin-2.58%Operating Margin2.27%
    ROE-12.30%ROIC1.83%
    Financial Health
    Debt/Equity1.98xInterest CoverageN/A
    Current Ratio0.97xQuick Ratio0.97x
    Trading Statistics
    Beta1.86Avg Volume2.08M
    52-Week High$26.1652-Week Low$8.55

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$22.28
    SMA 20$22.40
    SMA 50$20.52
    SMA 200$15.80
    EMA 10$21.78
    EMA 20$21.85
    EMA 50$20.85
    EMA 200$16.85

    MACD

    Line: 0.17Signal: 0.56Hist: -0.39

    ADX

    ADX: 30.6+DI: 26.6-DI: 19.1

    Aroon & PSAR

    Aroon Up72.0
    Aroon DownN/A
    PSAR$24.76

    Bollinger Bands

    Upper Band$25.53
    Lower Band$19.28
    %B Position2789%(Upper)
    Band Width0.43

    RSI (14-Day)

    Neutral
    51.5

    Momentum Oscillators

    Stoch %K21.9
    Stoch %D17.6
    Williams %R-64.6
    ROC (10d)-7.1%
    Momentum-1.67
    CCI (20d)-51.0
    MFI (14d)60.0

    Volatility Measures

    ATR (14d)$1.49(6.8%)
    StdDev (20d)1.56
    Hist Vol74.2%(High)

    Volume Flow

    VWAP$21.41
    OBV4.2M
    AD Line2.7M
    CMF (20d)0.123

    Volume Metrics

    Avg Vol (20d)2.1M
    Vol Ratio0.9x
    VWMA (20d)$22.60

    Pivot Points

    R3$21.79
    R2$21.29
    R1$20.88
    Pivot Point$20.38
    S1$19.97
    S2$19.47
    S3$19.06

    Advanced Oscillators

    TSI4.08
    Ultimate Osc45.5
    KST124.06

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$691.50M$678.20M$636.50M$660.50M$701.30M$710.30M$651.30M$697.00M$674.90M$662.40M$662.10M$709.70M
    Cost of Revenue$552.00M$539.00M$512.90M$529.40M$578.60M$576.80M$534.80M$556.10M$526.60M$525.30M$554.20M$577.90M
    Gross Profit$139.50M$139.20M$123.60M$131.10M$122.70M$133.50M$116.50M$140.90M$148.30M$137.10M$107.90M$131.80M
    Operating Expenses$124.50M$124.40M$127.00M$144.70M$131.30M$463.80M$636.60M$196.50M$166.30M$188.00M$145.30M$155.80M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$103.80M$102.10M$100.50M$103.00M$106.80M$124.80M$121.80M$148.10M$136.30M$156.20M$120.10M$126.70M
    Operating Income$15.00M$14.80M$-3,400,000$-13,600,000$-8,600,000$-330,300,000$-520,100,000$-55,600,000$-18,000,000$-50,900,000$-37,400,000$-24,000,000
    Interest Income$-20,200,000$-19,300,000$-19,100,000$-23,200,000$-22,600,000$-23,300,000$-22,300,000$-21,900,000$-22,400,000$-45,200,000$-34,300,000$0
    Interest Expense$18.60M$16.00M$8.90M$22.00M$20.10M$40.40M$27.90M$19.30M$17.80M$37.70M$38.30M$30.70M
    Income Before Tax$-3,600,000$-1,200,000$-12,300,000$-35,600,000$-28,700,000$-370,700,000$-548,000,000$-74,900,000$-35,800,000$-88,600,000$-75,700,000$-54,700,000
    Income Tax Expense$-4,200,000$12.00M$11.30M$-3,100,000$-12,800,000$4.20M$14.90M$-1,000,000$-17,300,000$10.70M$4.10M$-6,100,000
    Net Income$600,000$-13,200,000$-23,600,000$-32,500,000$-15,900,000$-374,900,000$-562,900,000$-61,200,000$-27,900,000$-138,400,000$-101,000,000$-54,500,000
    EBITDA$36.60M$37.70M$26.60M$6.90M$13.50M$-327,800,000$-506,200,000$-32,200,000$7.80M$-22,000,000$-17,900,000$4.20M
    EBIT$16.60M$18.10M$6.80M$-12,400,000$-6,100,000$-347,400,000$-525,700,000$-53,000,000$-13,400,000$-43,400,000$-41,400,000$-20,200,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about FTRE

    News

    111,271 Shares of Fortrea Holdings Inc. $FTRE Bought by Pullen Investment Management LLC

    Pullen Investment Management LLC recently acquired 111,271 shares of Fortrea Holdings Inc. (NASDAQ:FTRE) worth approximately $2.22 million...

    MarketBeat•10/26/26•Somewhat-Bullish

    Fortrea Holdings Inc. (NASDAQ:FTRE) Stock Now Rated "Hold" by Sell-Side Brokerages

    Sell-side brokerages have assigned an average "Hold" recommendation for Fortrea Holdings Inc. (NASDAQ:FTRE) stock, with a consensus among 12 analysts including seven buy ratings, three hold ratings...

    MarketBeat•10/26/26•Neutral

    Fortrea Holdings Inc. Estimates – NASDAQ:FTRE

    This article provides an overview of Fortrea Holdings Inc. (NASDAQ:FTRE) financial data and analyst estimates available on TradingView. It highlights key sections like income statement, balance sheet, cash flow...

    TradingView•10/23/26•Neutral

    Assenagon Asset Management S.A. Sells 100,436 Shares of Fortrea Holdings Inc. $FTRE

    Assenagon Asset Management S.A. significantly reduced its stake in Fortrea Holdings Inc. by selling 100,436 shares...

    MarketBeat•10/23/26•Somewhat-Bullish

    Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development

    Fortrea and Omico have announced a collaboration to accelerate precision oncology research, aiming to connect cancer patients with biomarker-matched clinical trials...

    GlobeNewswire•10/22/26•Bullish

    FTRE Valuation and Fair Value

    P/E
    28.9x
    Forward P/E
    10.7x
    EV/EBITDA
    27.4x
    P/FCF
    12.5x
    PEG
    0.3x
    P/B
    4.0x
    See GNG's fair value

    FTRE Profitability: Margins, ROIC and FCF

    Gross margin
    20.0%
    Operating margin
    2.3%
    Net margin
    -2.6%
    ROIC
    1.8%
    ROE
    -12.3%
    FCF margin
    6.3%
    FCF yield
    8.0%

    FTRE Competitors

    CompanyTicker
    Sarepta Therapeutics IncSRPT
    Veracyte IncVCYT
    Dentsply Sirona IncXRAY
    Inspire Medical Systems IncINSP
    Select Medical HoldingsSEM
    GeneDx Holdings Corp.WGS
    Avadel Pharmaceuticals PLCAVDL
    LeMaitre Vascular IncLMAT

    Sector: Healthcare

    FTRE Analyst Ratings

    Consensus
    Hold
    Analysts
    13
    Strong Buy
    1
    Buy
    6
    Hold
    4
    Sell
    1
    Strong Sell
    1

    FTRE Bull Case vs Bear Case

    Bear case

    • FTRE has a -2.6% net profit margin.
    • FTRE's quarterly revenue changed -1.4% year over year.

    FTRE Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    51.4%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.42

    FTRE Earnings Date

    FTRE reports Feb 24, 2027, before the open. The date is estimated.

    FTRE Earnings Call

    The latest FTRE earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    FTRE ETF Holders

    GNG tracks 14 ETFs that hold FTRE. The largest weights:

    1. First Trust Small Cap Growth AlphaDEX Fund (FYC), 0.77% of the fund
    2. iShares Biotechnology ETF (IBB), 0.16% of the fund
    3. iShares Core S&P Small-Cap ETF (IJR), 0.13% of the fund
    4. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.04% of the fund
    5. iShares Russell 2000 ETF (IWM), 0.03% of the fund
    Open the ETF Stock Exposure tool for FTRE

    Frequently Asked Questions About FTRE

    When does FTRE report earnings?

    Fortrea Holdings Inc. (FTRE) is expected to report earnings on Feb 24, 2027.

    Does FTRE pay dividends?

    Fortrea Holdings Inc. (FTRE) does not currently pay a regular dividend.

    What is FTRE's P/E ratio?

    Fortrea Holdings Inc. has a price-to-earnings (P/E) ratio of 28.89.

    What is FTRE's market cap?

    Fortrea Holdings Inc. (FTRE) has a market capitalization of $1.97B with a current stock price of $21.96.

    Related stocks

    Sector: Healthcare

    All stocks starting with F

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In